A Clinical Prospective Observational Study of Near Infrared Spectroscopy to Detect Subcranial Hematoma

Last updated: May 5, 2024
Sponsor: RenJi Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hemorrhage

Treatment

Near-infrared spectroscopy detection

Clinical Study ID

NCT06404645
LY2024-054-B
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This trial is a clinical prospective observational study. Cases meeting the entry criteria undergo near-infrared spectroscopy(NIRS）detection. Data collection mainly includes hematoma thickness on cranial CT, and bilateral NIRS data.This trial tries to explore the reliability and accuracy of NIRS detection of subcranial hematoma.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age above 18 years old
  2. Unilateral subcranial hemorrhage confirmed by cranial CT

Exclusion

Exclusion Criteria:

  1. Bilateral subcranial hemorrhage
  2. Intracranial pneumoperitoneum in the location of the hemorrhage on cranial CT
  3. Obvious skull fracture in the location of hemorrhage on cranial CT

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Near-infrared spectroscopy detection
Phase:
Study Start date:
May 01, 2024
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • Brain Injury Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

    Shanghai, Shanghai 201114
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.